Henry J Kaminski, MD Professor Neurological Institute University Hospitals School of Medicine Case Western Reserve University

NetWellness Articles associated with this Author:

	Article Name	Forum
	What Is Myasthenia Gravis?	Myasthenia Gravis
	What else do I need to know about Myasthenia Gravis?	Myasthenia Gravis
	What are the tests for Myasthenia Gravis?	Myasthenia Gravis
	What are the symptoms of Myasthenia Gravis?	Myasthenia Gravis
	What should I know about treatments for Myasthenia Gravis?	Myasthenia Gravis
	What is the role of the thymus and a thymectomy in Myasthenia Gravis?	Myasthenia Gravis
	Is there a cure for Myasthenia Gravis?	Myasthenia Gravis
	What medications can be taken by people with Myasthenia Gravis?	Myasthenia Gravis
	What conditions might be confused with Myasthenia Gravis?	Myasthenia Gravis
	What alternative therapies are available to treat Myasthenia Gravis?	Myasthenia Gravis
	Myasthenia Gravis - Frequently Asked Questions	Myasthenia Gravis
	Myasthenia Gravis Overview	Myasthenia Gravis

Practice Address:

University Hospitals of Cleveland
11100 Euclid Avenue
Cleveland, Ohio 44106

Cleveland VA Medical Center
10701 East Blvd
Cleveland, OH 44106

Education:

• Case Western Reserve University, Cleveland, Ohio, B.A. (Chemistry, Anthropology), 1981
• Case Western Reserve University School of Medicine, Cleveland, Ohio, Doctor of Medicine, 1985

Post Graduate Training:

• Residency Training, Internal Medicine, University Hospitals of Cleveland, 1985-1986
• Residency Training, Neurology, University Hospitals of Cleveland, 1986-1989
• Research Training, Cleveland Veterans Affairs Medical Center, Cleveland, Ohio, 1989-1992
• Honorary Research Associate, Department of Virology, St. Thomas's Hospital, London, England, 1992-1993

Licensure or Certification:

• 1986, State of Ohio Medical Board, #054207
• 1991, Diplomate American Board of Neurology and Psychiatry (Neurology) Certificate # 34435

Affiliations:

• 2003-present, Professor of Neurology and Neurosciences, Case Western Reserve University

Partial List of Publications:

• Wang ZY, Diethelm-Okita B, Okita DK, Kaminski HJ, Howard J, Conti-Fine BM. T-cell recognition of muscle acetylcholine receptor in ocular myasthenia gravis. J Neuroimmunol 2000;108:29-39.
• Richmonds CR, Kaminski HJ. Nitric oxide myotoxicity is age-related. Mech Ageing Dev 2000;113:183-191.
• Mygland Å, Vincent A, Newsom-Davis J, Kaminski H, Zorzato F, Agius M, Gilhus NE, Aarli JA. Autoantibodies in thymoma-associated myasthenia gravis with myositis or neuromyotonia. Arch Neurol 2000;57:527-531.
• Kaminski HJ, Daroff RB. Controversies in Neurology. Treatment of ocular myasthenia: steroids only when compelled. Arch Neurol 2000;57:752-753.
• Andrade FH, Porter JD, Kaminski HJ. Eye muscle sparing by the muscular dystrophies: Lessons to Be Learned? Microsc Res Tech 2000;48:192-203.
• Richmonds CR, Boonyapisit K, Kusner LL, Kaminski HJ. Nitric oxide synthase in aging skeletal muscle. Mech Ageing Dev 1999:109;177-189.
• Kusner LL, Kim E, Kaminski HJ. Hemeoxygenase II is concentrated at the neuromuscular junction. Neurosci Lett 199;273:143-146.
• Zaidat O, Kaminski HJ, Berenson F, Katirji B. Neuromuscular transmission defect caused by carbamazepine. Muscle Nerve 1999;22:1293-1296.
• Van Lunteren E, Kaminski HJ. Perturbations of sleep and breathing during sleep in neuromuscular disease. Sleep & Breathing 1999;3:23-30.
• Kaminski HJ. Achalasia and myasthenia gravis in a patient with thymoma. Neurology 1999;52:425-426.
• Boonyapisit K, Kaminski HJ, Ruff RL. The molecular basis of neuromuscular transmission disorders. Am J Med 1999;106:97-113.
• Kaminski HJ, Mygland ~, Kusner LL. Ryanodine receptor gene expression in thymomas. Muscle Nerve 1998;21:1299-1303.
• Kaminski HJ. Acetylcholine receptor epitopes in ocular myasthenia. Ann NY Acad Sci 1998;841:309-20.
• Kaminski HJ, Leigh RJ. Conference Report: International symposium for therapy of ocular motility and related visual disturbances. Neurology 1997;48:1178-84.
• Anagnos A, Ruff RL, Kaminski HJ. Neuromuscular manifestations of endocrine diseases. Neurol Clin 1997;15:673-96.
• Kaminski HJ, Suarez JI, Ruff RL. Physiology of the neuromuscular junction. Neurology 1997;48:S8-17.
• Kaminski HJ, Ruff RL. Ocular muscle involvement by myasthenia gravis. Ann Neurol 1997;41:419-20.
• Kaminski HJ, Kernich C, Kusner LL. Ocular myasthenia. Advances in Clinical Neuroscience 1996;6:37-54.
• Kusner LL, Kaminski HJ. Nitric oxide synthase concentrated at the skeletal muscle endplate. Brain Res 1996;730;238-42.
• Suarez J, Cohen ML, Kaminski HJ. Congenital neuromuscular diseases presenting in adulthood. Semin Neurol 1996;16:47-54.
• Kaminski HJ, Kusner LL, Block CH. Acetylcholine receptor isoform expression at extraocular muscle endplates. Invest Ophthalmol Vis Sci 1996; 37: 345-51 (erratum Invest Ophthalmol Vis Sci 1996; 37(8): 6A).
• Kaminski HJ, Tresser N, Hogan RE, Martin E. Spinal cord histopathology of long-term survivors of poliomyelitis. Muscle Nerve 1995; 18: 1208-9.
• Kaminski HJ, Kusner LL, Nash K, Ruff RL. The gamma-subunit of the acetylcholine receptor is not expressed in the levator palpebrae superioris. Neurology 1995; 45: 516-8.
• Kaminski HJ, Tresser N, Hogan RE, Martin, E. Pathological analysis of spinal cords from survivors of poliomyelitis. Ann NY Acad Sci 1994;753: 386-90.
• Muir P, Nicholson F, Sharief MK, Thompson EJ, Cairns NJ, Lantos P, Spencer GT, Kaminski HJ, Banatvala JE. Evidence for persistent enterovirus infection of the central nervous system in patients with previous paralytic poliomyelitis and post-polio syndrome. Ann NY Acad Sci 1994; 753: 2190-33.
• Hlavin ML, Kaminski HJ, Fenstermaker RA, White RJ. Intracranial suppuration: A modern decade of postoperative subdural empyema and epidural abscess. Neurosurgery 1994;34:974-81.
• Kaminski HJ, Fenstermaker RA, Abdul-Karim FW, Clayman J, Ruff RL. Acetylcholine receptor subunit mRNA expression in thymic tissue of myasthenics and non-myasthenics Muscle Nerve 1993;16:1332-37.
• Hlavin ML, Kaminski HJ, Cohen M, Abdul-Karim FW, Ganz E. Central nervous system complications of cystosarcoma phylloides. Cancer 1993;72:126-30.
• Kaminski HJ, Ruff RL. Post-polio syndrome. Advances in Clinical Neuroscience 1992;2:189-96.
• Kaminski HJ, Fenstermaker RA, Ruff RL, Abdul-Karim FA, Clayman J. Myf-4 does not mediate AChR receptor subunit mRNA expression in thymic tissues. Ann NY Acad Sci 1993;681:103-6.
• Kaminski HJ, Ruff RL. Insights into possible skeletal muscle nicotinic acetylcholine receptor (AChR) changes in some congenital myasthenias from physiological studies, point mutations and subunit substitutions of the AChR. Ann NY Acad Sci 1993;681:435-50.
• Kaminski HJ, Al-Hakim M, Leigh RJ, Katirji MB, Ruff RL. Extraocular muscles are spared in advanced Duchenne dystrophy. Ann Neurol 1992;32:586-8.
• Kaminski HJ, Ruff RL. Congenital disorders of neuromuscular transmission. Hosp Prac 1992;27:73-85.
• Kaminski HJ, Adams N, Burstine TH, Civil RH, Ruff RL. The relation of aphemia and agraphia. Europ Neurol 1992;32:302-4.
• Kaminski HJ, Hlavin ML, Likavec MJ, Schmidley JW. Transient neurologic deficit caused by chronic subdural hematoma. Am J Med 1992;92:698-700.
• Kaminski HJ, Ruff RL. Headache in the elderly. Current Therapeutics 1991;32:63-8.
• Kaminski HJ, Zee DS, Leigh RJ, Mendez MF. Ocular flutter and ataxia associated with AIDS-related complex. Neuro-ophthalmol 1991;11:163-167.
• Kaminski HJ, Diwan VG, Ruff RL. Second occurrence of spinal epidural metastases. Neurology 1991;41:744-6.
• Sullivan HC, Kaminski HJ, Maas EF, Weismann JD, Leigh RJ. Lateral deviation of the eyes on forced lid closure in patients with cerebral lesions. Arch Neurol 1991;48:310-311.
• Kaminski HJ, Ruff RL. Treatment of headache and trigeminal neuralgia in the elderly. Drugs & Aging 1991;1:48-56.
• Kaminski HJ, Maas E, Spiegel P, Ruff RL. Why are eye muscles frequently involved in myasthenia gravis? Neurology 1990;40:1663-1669.
• Hlavin ML, Kaminski HJ, Ross JS, Ganz E. Epidural abscess: A ten year perspective. Neurosurgery 1990;27:177-84 (Article selected for review in the Yearbook of Neurology and Neurosurgery).
• Ruff RL, Kaminski HJ, Maas E, Spiegel P. Ocular muscles: Physiology and structure-function correlations. Bull Soc belg Ophtalmol 1989;237:321-352.
• Kaminski HJ, Ruff RL. Neurological complications of endocrine disease. Neurol Clin 1989;7:489-508.
• Kaminski HJ, Katzman M, Weist PM, Ellner JM, Gifford DR, et al. Cardiomyopathy associated with the acquired immunodeficiency syndrome. J Ac Immun Def Synd 1988;1:105-10.
• Wolfe G, Kaminski HJ. Autoantibody testing in neuromuscular disorders, Part I: Peripheral neuropathies. J Clin Neuromusc Dis 2000;2:84-95.
• Kaminski HJ, Santillan C, Wolfe G. Autoantibody testing in neuromuscular disorders, Part II: Neuromuscular junction, hyperexcitability, and muscle disorders. J Clin Neuromusc Dis 2000;2:96-105.

Hospital Appointments:

• 1993-present, Attending Neurologist, Cleveland Veterans Affairs Medical Center
• 1993-present, Director, Myasthenia Gravis Center, University Hospitals of Cleveland

Grants:

• Principal Investigator, National Eye Institute, Nitric Oxide Systems in Normal and Diseased Ocular Muscle, R01 EY-11998, 1998-2001, Direct Costs: $328,248.
• Investigator Member, Core Facility for Visual Sciences, National Eye Institute, 1997-2002, Direct Costs: $1,200,000.
• Principal Investigator, Merit Review, Department of Veterans Affairs, The Fetal Acetylcholine Receptor and Myasthenia Gravis, 1997-2000, Direct Costs: $188,700.
• Principal Investigator, Pilot Project in Aging Research, National Institutes of Aging Through the CWRU Pepper Older Americans Independence Center, 1996-8, Direct Costs: $9,000.
• Application Coordinator (other applicants: R. John Leigh, Robert L. Ruff, John Stahl), Medical Research Equipment Allocation, Magnetic Eye Movement Recording System and Motion Analysis System, Department of Veterans Affairs, Direct Costs: $106,392.
• Sponsor, Myasthenia Gravis Foundation of America, Animal Models of Ocular Myasthenia, Student Summer Stipend for Edward Kim, 6-8/98, Direct Costs: $3,000.
• Sponsor, Myasthenia Gravis Foundation of America, Cardiopulmonary Complications of Sleep Disturbance Among Patients with Myasthenia Gravis, Student Summer Stipend for Regina Cho, 6-8/98, Direct Costs: $3,000.
• Principal Investigator, Research Advisory Group, Department of Veterans Affairs, Ocular Muscle Involvement by Myasthenia Gravis, 1993-5, Direct Costs: $92,100.
• Principal Investigator, National Eye Institute, Ocular Muscle Involvement by Myasthenia Gravis, K29 EY-00332, 1993-8, Direct Costs: $381,820.
• Principal Investigator, Ohio Regents Challenge Grant, PolioVirus Detection by RT-PCR in Patients with Post-Polio Syndrome, 1992, Direct Costs: $5,000.
• Principal Investigator, National Eye Institute, Expression of Acetylcholine Receptor mRNA in Extraocular Muscle, R03 EY09186, 1991-2, Direct Costs: $46,000.
• Associate Investigator Award in the Department of Veterans Affairs Career Development Program, Sodium Channel Gating in Animal Models of Myotonia. Preceptor, Robert L. Ruff, M.D., Ph.D., 1989-92, Direct Costs: $183,000.

Awards:

• 1999 - Elected member American Neurological Association
• 1998 - Doctor's Award, Myasthenia Gravis Foundation of America
• 1995 - Lois Seimer Award, Myasthenia Gravis Foundation, Ohio Chapter
• 1994 - Certificate of Appreciation, Myasthenia Gravis Foundation, Ohio Chapter
• 1993 - Osserman Fellow, Myasthenia Gravis Foundation of America
• 1991 - Fellow of the Stroke Council of the American Heart Association
• 1985 - Department of Neurology Award, Case Western Reserve University School of Medicine
• 1981 - Cleveland Metropolitan General Hospital Summer Scholar
• 1981 - Magna Cum Laude graduate Case Western Reserve University
• 1981 - Elected Phi Beta Kappa
• 1979-1981 - Western Reserve Scholar